Literature DB >> 34319202

The digital divide: factors impacting on uptake of remote therapy in a South London psychological therapy service for people with psychosis.

Andrew Watson1, Harriet Mellotte2, Amy Hardy1,2, Emmanuelle Peters1,2, Nadine Keen2, Fergus Kane2.   

Abstract

BACKGROUND: Remote therapy promises a cost-effective way of increasing delivery of psychological-therapy in underserved populations. However, research shows a "digital divide", with some groups experiencing digital exclusion. AIMS: To assess whether technology, accessibility, and demographic factors influence remote therapy uptake among individuals with psychosis, and whether demographic factors are associated with digital exclusion.
METHODS: Remote therapy uptake and demographics were assessed in people (n = 51) within a psychology-led service for psychosis, using a survey of access to digital hardware, data and private space.
RESULTS: The majority of individuals had access to digital devices, but 29% did not meet minimum requirements for remote therapy. Nineteen (37%) individuals declined remote therapy. Those who accepted were significantly younger and more likely to have access to technology than those who declined. The mean age of those with access to smartphones and large screen devices was younger than those without access.
CONCLUSIONS: A subgroup of people with psychosis face barriers to remote therapy and a significant minority are digitally excluded. Older age is a key factor influencing remote therapy uptake, potentially related to less access to digital devices. Services must minimize exclusion through provision of training, hardware and data, whilst promoting individual choice.

Entities:  

Keywords:  Digital therapy; digital divide; psychosis; remote therapy; teletherapy

Year:  2021        PMID: 34319202     DOI: 10.1080/09638237.2021.1952955

Source DB:  PubMed          Journal:  J Ment Health        ISSN: 0963-8237


  5 in total

Review 1.  Synthesis of the Evidence on What Works for Whom in Telemental Health: Rapid Realist Review.

Authors:  Merle Schlief; Katherine R K Saunders; Rebecca Appleton; Phoebe Barnett; Norha Vera San Juan; Una Foye; Rachel Rowan Olive; Karen Machin; Prisha Shah; Beverley Chipp; Natasha Lyons; Camilla Tamworth; Karen Persaud; Monika Badhan; Carrie-Ann Black; Jacqueline Sin; Simon Riches; Tom Graham; Jeremy Greening; Farida Pirani; Raza Griffiths; Tamar Jeynes; Rose McCabe; Brynmor Lloyd-Evans; Alan Simpson; Justin J Needle; Kylee Trevillion; Sonia Johnson
Journal:  Interact J Med Res       Date:  2022-09-29

2.  Bridging the Digital Divide in Psychological Therapies: Observational Study of Engagement With the SlowMo Mobile App for Paranoia in Psychosis.

Authors:  Amy Hardy; Thomas Ward; Richard Emsley; Kathryn Greenwood; Daniel Freeman; David Fowler; Elizabeth Kuipers; Paul Bebbington; Philippa Garety
Journal:  JMIR Hum Factors       Date:  2022-07-01

3.  Multisite randomised controlled trial of trauma-focused cognitive behaviour therapy for psychosis to reduce post-traumatic stress symptoms in people with co-morbid post-traumatic stress disorder and psychosis, compared to treatment as usual: study protocol for the STAR (Study of Trauma And Recovery) trial.

Authors:  Emmanuelle Peters; Amy Hardy; Robert Dudley; Filippo Varese; Kathryn Greenwood; Craig Steel; Richard Emsley; Nadine Keen; Samantha Bowe; Sarah Swan; Raphael Underwood; Eleanor Longden; Sarah Byford; Laura Potts; Margaret Heslin; Nick Grey; Doug Turkington; David Fowler; Elizabeth Kuipers; Anthony Morrison
Journal:  Trials       Date:  2022-05-23       Impact factor: 2.728

4.  Do cognitive impairments limit treatment gains in a standalone digital intervention for psychosis? A test of the digital divide.

Authors:  Daniel Fulford; Elizabeth Schupbach; David E Gard; Kim T Mueser; Jessica Mow; Lawrence Leung
Journal:  Schizophr Res Cogn       Date:  2022-02-24

5.  Telepsychiatry services during COVID-19: A cross-sectional survey on the experiences and perspectives of young adults with first-episode psychosis.

Authors:  Shalini Lal; Amal Abdel-Baki; Hajin Lee
Journal:  Early Interv Psychiatry       Date:  2022-06-22       Impact factor: 2.721

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.